|
1
|
Kim CH, Jeon GH, Cheon YP, Jeon I, Kim SH,
Chae HD and Kang BM: Comparison of GnRH antagonist protocol with or
without oral contraceptive pill pretreatment and GnRH agonist
low-dose long protocol in low responders undergoing
IVF/intracytoplasmic sperm injection. Fertil Steril. 92:1758–1760.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Devroey P, Aboulghar M, Garcia-Velasco J,
Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C and
Fauser BC: Improving the patient's experience of IVF/ICSI: A
proposal for an ovarian stimulation protocol with GnRH antagonist
co-treatment. Hum Reprod. 24:764–774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Inany HG, Youssef MA, Aboulghar M,
Broekmans F, Sterrenburg M, Smit J and Abou-Setta AM:
Gonadotrophin-releasing hormone antagonists for assisted
reproductive technology. Cochrane Database Syst Rev.
5:CD0017502011.PubMed/NCBI
|
|
4
|
Griesinger G, Kolibianakis EM, Venetis C,
Diedrich K and Tarlatzis B: Oral contraceptive pretreatment
significantly reduces ongoing pregnancy likelihood in
gonadotropin-releasing hormone antagonist cycles: An updated
meta-analysis. Fertil Steril. 94:2382–2384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kolibianakis EM, Papanikolau EG, Camus M,
Tournaye H, Van Steirteghem AC and Devroey P: Effect of oral
contraceptive pill pretreatment on ongoing pregnancy rates in
patients stimulated with GnRH antagonists and recombinant FSH for
IVF. A randomized controlled trial. Hum Reprod. 21:352–357. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rombauts L, Healy D and Norman RJ:
Comparative randomized trial to assess the impact of oral
contraceptive pretreatment on follicular growth and hormone
profiles in GnRH antagonist-treated patients. Hum Reprod.
21:95–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gizzo S, Andrisani A, Noventa M, Manfè S,
Oliva A, Gangemi M, Nardelli GB and Ambrosini G: Recombinant LH
supplementation during IVF cycles with a GnRH-antagonist in
estimated poor responders: A cross-matched pilot investigation of
the optimal daily dose and timing. Mol Med Rep. 12:4219–4229.
2015.PubMed/NCBI
|
|
8
|
Alviggi C, Clarizia R, Mollo A, Ranieri A
and De Placido G: Who needs LH in ovarian stimulation? Reprod
Biomed Online. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gizzo S, Quaranta M, Andrisani A, Bordin
L, Vitagliano A, Esposito F, Venturella R, Zicchina C, Gangemi M
and Noventa M: Serum stem cell factor assay in elderly poor
responder patients undergoing IVF: A new biomarker to customize
follicle aspiration cycle by cycle. Reprod Sci. July 7–2015.((Epub
ahead of print))
|
|
10
|
Hill MJ, Levens ED, Levy G, Ryan ME,
Csokmay JM, DeCherney AH and Whitcomb BW: The use of recombinant
luteinizing hormone in patients undergoing assisted reproductive
techniques with advanced reproductive age: a systematic review and
meta-analysis. Fertil Steril. February 24–2012.((Epub ahead of
print)). View Article : Google Scholar
|
|
11
|
König TE, van der Houwen LE, Overbeek A,
Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, Renckens CN,
Bernardus RE, Schats R, Homburg R, et al: Recombinant LH
supplementation to a standard GnRH antagonist protocol in women of
35 years or older undergoing IVF/ICSI: A randomized controlled
multicentre study. Hum Reprod. 28:2804–2812. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
König TE, van der Houwen LE and Lambalk
CB: Recombinant LH supplementation in women of 35 years and older
undergoing IVF? Fertil Steril. 98:e10–e11. 2012. View Article : Google Scholar
|
|
13
|
Schmitz C, Bocca S, Beydoun H, Stadtmauer
L and Oehninger S: Does the degree of
hypothalamic-pituitary-ovarian recovery after oral contraceptive
pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist
adjuvant therapy in women over 35 years of age? J Assist Reprod
Genet. 29:877–882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Desai SS, Roy BS and Mahale SD: Mutations
and polymorphisms in FSH receptor: functional implications in human
reproduction. Reproduction. 146:R235–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferraretti AP, La Marca A, Fauser BC,
Tarlatzis B, Nargund G and Gianaroli L: ESHRE Working Group On Poor
Ovarian Response Definition: ESHRE consensus on the definition of
‘poor response’ to ovarian stimulation for in vitro
fertilization: The Bologna criteria. Hum Reprod. 26:1616–1624.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patrelli TS, Gizzo S, Sianesi N, Levati L,
Pezzuto A, Ferrari B and Modena A Bacchi: Anti-Müllerian hormone
serum values and ovarian reserve: Can it predict a decrease in
fertility after ovarian stimulation by ART cycles? PLoS One.
7:e445712012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gizzo S, Andrisani A, Esposito F, Oliva A,
Zicchina C, Capuzzo D, Gangemi M and Nardelli GB: Ovarian reserve
test: An impartial means to resolve the mismatch between
chronological and biological age in the assessment of female
reproductive chances. Reprod Sci. 21:632–639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Litta P, D'Agostino G, Conte L, Saccardi
C, Cela V, Angioni S and Plebani M: Anti-Müllerian hormone trend
after laparoscopic surgery in women with ovarian endometrioma.
Gynecol Endocrinol. 29:452–454. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patrelli TS, Berretta R, Gizzo S, Pezzuto
A, Franchi L, Lukanovic A, Nardelli GB and Modena AB: CA 125 serum
values in surgically treated endometriosis patients and its
relationships with anatomic sites of endometriosis and pregnancy
rate. Fertil Steril. 95:393–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
World Health Organization: WHO Laboratory
Manual for the Examination of Human Semen and Sperm-Cervical Mucus
Interaction. Cambridge University Press; Cambridge, UK: 1999
|
|
21
|
Litta P, Cosmi E, Saccardi C, Esposito C,
Rui R and Ambrosini G: Outpatient operative polypectomy using a 5
mm-hysteroscope without anaesthesia and/or analgesia: Advantages
and limits. Eur J Obstet Gynecol Reprod Biol. 139:210–214. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saccardi C, Conte L, Fabris A, De Marchi
F, Borghero A, Gizzo S and Litta P: Hysteroscopic enucleation in
toto of submucous type 2 myomas: Long term follow up in women
affected by menorrhagia. J Minim Invasive Gynecol. 21:426–430.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Litta P, Spiller E, Saccardi C, Ambrosini
G, Caserta D and Cosmi E: Resectoscope or Versapoint for
hysteroscopic metroplasty. Int J Gynaecol Obstet. 101:39–42. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmitz C, Bocca S, Beydoun H, Stadtmauer
L and Oehninger S: Does the degree of
hypothalamic-pituitary-ovarian recovery after oral contraceptive
pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist
adjuvant therapy in women over 35 years of age? J Assist Reprod
Genet. 29:877–882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gizzo S, Andrisani A, Noventa M, Quaranta
M, Esposito F, Armanini D, Gangemi M, Nardelli GB, Litta P,
D'Antona D and Ambrosini G: Menstrual cycle length: a surrogate
measure of reproductive health capable of improving the accuracy of
biochemical/sonographical ovarian reserve test in estimating the
reproductive chances of women referred to ART. Reprod Biol
Endocrinol. April 10–2015.((Epub ahead of print)). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gizzo S, Andrisani A, Esposito F, Noventa
M, Di Gangi S, Angioni S, Litta P, Gangemi M and Nardelli GB: Which
luteal phase support is better for each IVF stimulation protocol to
achieve the highest pregnancy rate? A superiority randomized
clinical trial. Gynecol Endocrinol. September 30–2014.((Epub ahead
of print)). PubMed/NCBI
|
